Previous Nav
Net Change on 13-12-2019
PersonalFN Rating
Category
Assets (Cr.)
Expense Ratio
Fund House
Launch Date
Benchmark
Minimum Investment (₹)
Minimum Addl Investment (₹)
Exit Load (%)
Minimum SIP Investment (₹)
Minimum STP Investment (₹)
Minimum SWP Investment (₹)
52 Week Low Nav (₹)
52 Week Low Nav Date
52 Week High Nav (₹)
52 Week High Nav Date
Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised
Clearing Corporation of India Limited
Sun Pharmaceutical Industries Limited
Cipla Limited
Lupin Limited
Alkem Laboratories Limited
Divi's Laboratories Limited
Apollo Hospitals Enterprise Limited
Atul Limited
Torrent Pharmaceuticals Limited
Dr. Reddy's Laboratories Limited
Zydus Wellness Limited
Pfizer Limited
METROPOLIS HEALTHCARE LIMITED
Sanofi India Limited
Biocon Limited
Dishman Carbogen Amcis Limited
Strides Pharma Science Limited
Eris Lifesciences Limited
ALEMBIC PHARMACEUTICALS LIMITED
Avenue Therapeutics Inc
ICICI Lombard General Insurance Company Limited
IPCA Laboratories Limited
Narayana Hrudayalaya Limited
Aster DM Healthcare Limited
Natco Pharma Limited
Net Receivables / (Payables)
Pharmaceuticals & Drugs
Hospital & Healthcare Services
Chemicals
Consumer Food
Miscellaneous
Insurance
Aditya Birla Sun Life Pharma & Healthcare Fund is a Equity - Sectoral Fund - Pharma & Health Care fund and belongs to Aditya Birla Sun Life Mutual Fund. It was launched on 10-Jul-2019 and currently has an AUM of ₹173.24 crore. Aditya Birla Sun Life Pharma & Healthcare Fund is benchmarked against S&P BSE Health Care - TRI as primary index.
The NAV of Aditya Birla Sun Life Pharma & Healthcare Fund ended up ₹0.02(0.19%)yesterday to ₹10.56.
Among its top 3 holdings the fund has exposure to Clearing Corporation of India Limited, Sun Pharmaceutical Industries Limited and Cipla Limited
The Aditya Birla Sun Life Pharma & Healthcare Fund is managed by Dhaval Shah .
One India Bulls Centre , Tower 1, 17th Floor, Jupiter Mill Compound, 841, Senapati Bapat Marg, Elphinstone Road, Mumbai - 400 013
Cash
Equity